ReP USP - Resultado da busca

Filtros : "Canadá" "IMT" Removidos: "Malásia" "ESALQ-LZT" "Sociedade Brasileira de Física" Limpar

Filtros

USP affiliated authors
- chacra, nádia araci bou (2)
- kanashiro, edite hatsumi yamashiro (2)
- araujo, gabriel lima barros de (1)
- barbosa, eduardo josé (1)
- cotrim, paulo cesar (1)

Artigo de periodico
Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum (2022)
Monteiro, Lis Marie ; Löbenberg, Raimar ; Barbosa, Eduardo José ; Araujo, Gabriel Lima Barros de ; Sato, Paula Keiko ; Kanashiro, Edite Hatsumi Yamashiro ; Eliodoro, Raissa Heloisa de Araujo; Rocha, Mussya; Freitas, Vera Lucia Teixeira de ; Fotaki, Nikoletta; Bou-Chacra, Nadia Araci
Source: European Journal of Pharmaceutical Sciences. Unidades: FCF, IMT, FM
Subjects: LIPÍDEOS, LEISHMANIOSE VISCERAL, DOENÇAS NEGLIGENCIADAS, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEIRO, Lis Marie et al. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum. European Journal of Pharmaceutical Sciences, v. 169, p. 1-11 art. 106097, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2021.106097. Acesso em: 09 nov. 2024.
APA
Monteiro, L. M., Löbenberg, R., Barbosa, E. J., Araujo, G. L. B. de, Sato, P. K., Kanashiro, E. H. Y., et al. (2022). Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum. European Journal of Pharmaceutical Sciences, 169, 1-11 art. 106097. doi:10.1016/j.ejps.2021.106097
NLM
Monteiro LM, Löbenberg R, Barbosa EJ, Araujo GLB de, Sato PK, Kanashiro EHY, Eliodoro RH de A, Rocha M, Freitas VLT de, Fotaki N, Bou-Chacra NA. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 169 1-11 art. 106097.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejps.2021.106097
Vancouver
Monteiro LM, Löbenberg R, Barbosa EJ, Araujo GLB de, Sato PK, Kanashiro EHY, Eliodoro RH de A, Rocha M, Freitas VLT de, Fotaki N, Bou-Chacra NA. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 169 1-11 art. 106097.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejps.2021.106097
Artigo de periodico
Targeting Leishmania amazonensis amastigotes through macrophage internalisation of a hydroxymethylnitrofurazone nanostructured polymeric system (2017)
Monteiro, Lis Marie; Löbenberg, Raimar; Ferreira, Elizabeth Igne ; Cotrim, Paulo César; Kanashiro, Edite Hatsumi Yamashiro; Rocha, Mussya; Chung, Man Chin; Bou-Chacra, Nadia Araci
Source: International Journal of Antimicrobial Agents. Unidades: FCF, FM, IMT
Subjects: LEISHMANIA, MACRÓFAGOS, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEIRO, Lis Marie et al. Targeting Leishmania amazonensis amastigotes through macrophage internalisation of a hydroxymethylnitrofurazone nanostructured polymeric system. International Journal of Antimicrobial Agents, v. 50, n. 1, p. 88-92, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ijantimicag.2017.01.033. Acesso em: 09 nov. 2024.
APA
Monteiro, L. M., Löbenberg, R., Ferreira, E. I., Cotrim, P. C., Kanashiro, E. H. Y., Rocha, M., et al. (2017). Targeting Leishmania amazonensis amastigotes through macrophage internalisation of a hydroxymethylnitrofurazone nanostructured polymeric system. International Journal of Antimicrobial Agents, 50( 1), 88-92. doi:10.1016/j.ijantimicag.2017.01.033
NLM
Monteiro LM, Löbenberg R, Ferreira EI, Cotrim PC, Kanashiro EHY, Rocha M, Chung MC, Bou-Chacra NA. Targeting Leishmania amazonensis amastigotes through macrophage internalisation of a hydroxymethylnitrofurazone nanostructured polymeric system [Internet]. International Journal of Antimicrobial Agents. 2017 ; 50( 1): 88-92.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ijantimicag.2017.01.033
Vancouver
Monteiro LM, Löbenberg R, Ferreira EI, Cotrim PC, Kanashiro EHY, Rocha M, Chung MC, Bou-Chacra NA. Targeting Leishmania amazonensis amastigotes through macrophage internalisation of a hydroxymethylnitrofurazone nanostructured polymeric system [Internet]. International Journal of Antimicrobial Agents. 2017 ; 50( 1): 88-92.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ijantimicag.2017.01.033

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024